Member access

4-Traders Homepage  >  Shares  >  Xetra (Allemagne)  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

 (BAYN)
92
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra (Allemagne)
05/20/2013 05/21/2013 05/22/2013 05/23/2013 05/24/2013 Date
84.12(c) 84.65(c) 85.5(c) 83.91(c) 84.46(c) Last
1 002 671 1 575 244 2 234 179 2 095 137 2 274 801 Volume
+0.39% +0.63% +1.00% -1.86% +0.66% Change
More quotes
Company
Bayer is one of the world's leaders in designing, producing, and marketing pharmaceutical products and high-performance materials. Sales (not including sold divisions) are distributed by product family as follows: - healthcare products (46,8%): pharmaceutical products (58% of sales; intended for... 
Read more
Sector
Pharmaceuticals - Diversified
Calendar
06/04 | 09:00amPresentation
Surperformance© rating of Bayer AG
Trading Rating : Investor Rating :
More about the company
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Financials (€)
Sales 2013 41 379 M
EBIT 2013 6 129 M
Net income 2013 3 346 M
Debt 2013 5 699 M
Yield 2013 2,43%
Sales 2014 43 609 M
EBIT 2014 6 823 M
Net income 2014 3 757 M
Debt 2014 3 728 M
Yield 2014 2,70%
PER 2013 19,25
PER 2014 16,66
EV / Sales 2013 1,81x
EV / Sales 2014 1,68x
Capitalization 69 389 M
More Financials
Latest news on BAYER AG
1d ago BAYER AG: Decision to restrict use of neonicotinoid-containing products will no..
1d agoDJEU to Restrict 3 Pesticides Suspected of Killing Bees
1d ago BAYER AG: Bayer SeedGrowth™: the fully integrated system for on-seed applicatio..
3d ago BAYER AG: Global specialist network for sustainable building grows
3d ago BAYER AG: Johannes Schubmehl appointed CIO of Bayer HealthCare
4d ago Analysis - German households pay for lower industrial power prices
4d ago BAYER AG: Bayer opens Innovation Hub for Asia Pacific
4d ago BAYER AG: Bayer Presents Positive Interim Results from Long-term Extension Stud..
05/17 BAYER AG: Bayer Submits Investigational Drug Riociguat for Patients with Chroni..
05/16 BAYER AG: Bayer to acquire Steigerwald Arzneimittelwerk GmbH
05/16DJBAYER AG: Bayer Buys Privately Held Pharmaceutical Firm in Darmstadt
05/16 BAYER AG: Bayer to Present New Data Across Oncology Portfolio at ASCO 2013
More news
Forum BAYER AG
Be the first to post a message on BAYER AG
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
Bayer AG : Income Statement Evolution
More Financials
EPS Revisions
Bayer AG : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.